Shares Outstanding (Quarterly) Chart

View Shares Outstanding (Quarterly) for VSTM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shares Outstanding (Quarterly) Chart
Start Trial

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 2011. Start Trial.
Date Value
June 30, 2026 90.48M
March 31, 2026 87.84M
December 31, 2025 77.74M
September 30, 2025 66.75M
June 30, 2025 61.52M
March 31, 2025 51.49M
December 31, 2024 44.78M
September 30, 2024 40.26M
June 30, 2024 26.88M
March 31, 2024 25.31M
December 31, 2023 25.28M
September 30, 2023 25.26M
June 30, 2023 25.24M
March 31, 2023 16.71M
December 31, 2022 16.71M
September 30, 2022 17.51M
June 30, 2022 15.63M
March 31, 2022 15.53M
December 31, 2021 15.44M
September 30, 2021 15.18M
June 30, 2021 14.34M
March 31, 2021 14.31M
December 31, 2020 14.20M
September 30, 2020 14.13M
June 30, 2020 14.11M
Date Value
March 31, 2020 13.53M
December 31, 2019 6.676M
September 30, 2019 6.193M
June 30, 2019 6.156M
March 31, 2019 6.156M
December 31, 2018 6.150M
September 30, 2018 6.142M
June 30, 2018 6.132M
March 31, 2018 4.247M
December 31, 2017 4.233M
September 30, 2017 3.329M
June 30, 2017 3.083M
March 31, 2017 3.083M
December 31, 2016 3.083M
September 30, 2016 3.083M
June 30, 2016 3.083M
March 31, 2016 3.083M
December 31, 2015 3.078M
September 30, 2015 3.078M
June 30, 2015 3.071M
March 31, 2015 3.013M
December 31, 2014 2.272M
September 30, 2014 2.156M
June 30, 2014 2.144M
March 31, 2014 2.134M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. 172.13M
Dianthus Therapeutics, Inc. 54.80M
Alnylam Pharmaceuticals, Inc. 133.73M
Anika Therapeutics, Inc. 13.38M
Savara, Inc. 205.40M